Ducentis Bio
  • Home
  • Our Technology
  • Our Team
    • Management
    • Board Members
  • Investors
  • Contact Us

Investors

Picture
Prosarix

LifeArc

LifeArc Ventures focus on funding companies in Seed and Series A rounds, with significant follow-on investment available for exceptional portfolio companies. LifeArc Ventures bring value by providing both funding and expertise from our internal LifeArc diligence, therapeutic and diagnostic teams; focussing on areas where new treatments are needed most, and where novel technologies and modalities can be developed to improve patient health outcomes or transform healthcare pathway. LifeArc Ventures invest alongside other like-minded investors to de-risk technologies, and work in partnership with global investors to secure further venture investment in later rounds and unlock their prospective value.
www.lifearc.org
Syngene

Oxford Technology Management

Founded in 1983, Oxford Technology Management (OTM) is a venture capital firm based in Oxford, UK. Most OTM investments are routed through EIS/SEIS eligible Venture Capital Trusts. The company makes seed, early-stage, and later-stage investments in therapeutics, healthcare devices, and life science technology in the United Kingdom.
www.oxfordtechnology.com

Ducentis

Our Technology  |  Management  |  Board Members

Connect

Contact Us

Legals

Disclaimer
​Ducentis BioTherapeutics Ltd is a company registered in England. 
Registered office address:
264 Banbury Road, Oxford, Oxfordshire, OX2 7DY
Company registration number: 9307415.
© Copyright Ducentis BioTherapeutics 2022   |   Website Design & Development by Creative Remedy
  • Home
  • Our Technology
  • Our Team
    • Management
    • Board Members
  • Investors
  • Contact Us